Stay updated on EPCORE™ NHL-1 Clinical Trial
Sign up to get notified when there's something new on the EPCORE™ NHL-1 Clinical Trial page.

Latest updates to the EPCORE™ NHL-1 Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference2%

- Check27 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.0%

- Check42 days agoChange DetectedPage revision updated to v3.0.2, replacing v3.0.1. The Back to Top element was removed.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page has been updated to reflect a new version (v3.0.1) and includes new dates for updates, replacing the previous version's dates.SummaryDifference0.4%

- Check56 days agoChange DetectedThe webpage has been updated to include new facility names and locations, particularly in South Korea and Poland, as well as detailed drug information regarding Epcoritamab and related studies. Several previous location terms and related topics have been removed.SummaryDifference13%

- Check70 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.4%

Stay in the know with updates to EPCORE™ NHL-1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EPCORE™ NHL-1 Clinical Trial page.